Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Washington University School of Medicine
Novartis
Pfizer
Seagen Inc.
AIDS Malignancy Consortium
University Health Network, Toronto
Tocagen Inc.
Incyte Corporation